In fact, there are many reports that CASC9 is involved in non-small cell lung carcinoma, bladder cancer, thyroid cancer, hepatocellular carcinoma, nasopharyngeal cancer, and lung cancer (Jin et al., 2019; Zeng et al., 2019; Chen Y. et al., 2020; Huo et al., 2020; Zhao et al., 2020). This evidence concerns the gene CASC9 and lung cancer.